Cape Verde vs Guatemala: Antiretroviral therapy coverage for PMTCT
Cape Verde
80.0%
in 2024
Guatemala
82.0%
in 2023
Cape Verde rank
41st
Guatemala rank
38th
Antiretroviral therapy coverage for PMTCT over time
- Cape Verde
- Guatemala
How they compare
Guatemala currently reports 82.0% against 80.0% in Cape Verde, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Guatemala ahead.
Cape Verde ranks 41st and Guatemala ranks 38th of 84 countries.
Across the 3 decades both report, Cape Verde averaged higher in 2 and Guatemala in 1.
Head to head by decade
| Decade | Cape Verde | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 23.8% | 23.8% | Guatemala |
| 2010s | 100.0% | 54.3% | 45.7% | Cape Verde |
| 2020s | 91.0% | 75.0% | 16.0% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cape Verde or Guatemala?
- Guatemala, at 82.0% against 80.0% in Cape Verde as of 2023.
- What is the difference in antiretroviral therapy coverage for pmtct between Cape Verde and Guatemala?
- 2.0%, with Guatemala ahead.
- How many years of comparable data are there for Cape Verde and Guatemala?
- 24 years are reported by both, from 2000 to 2023.
- How do Cape Verde and Guatemala rank globally for antiretroviral therapy coverage for pmtct?
- Cape Verde ranks 41st and Guatemala ranks 38th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).